ATE334232T1 - Pharmakologische anwendungen von mitochondriellen dna assays - Google Patents
Pharmakologische anwendungen von mitochondriellen dna assaysInfo
- Publication number
- ATE334232T1 ATE334232T1 AT02729732T AT02729732T ATE334232T1 AT E334232 T1 ATE334232 T1 AT E334232T1 AT 02729732 T AT02729732 T AT 02729732T AT 02729732 T AT02729732 T AT 02729732T AT E334232 T1 ATE334232 T1 AT E334232T1
- Authority
- AT
- Austria
- Prior art keywords
- subject
- assays
- mitochondrial dna
- mitochondrial
- dna assay
- Prior art date
Links
- 238000003556 assay Methods 0.000 title abstract 4
- 108020005196 Mitochondrial DNA Proteins 0.000 title abstract 3
- 230000000144 pharmacologic effect Effects 0.000 title 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 108091093105 Nuclear DNA Proteins 0.000 abstract 1
- 238000002944 PCR assay Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 230000002438 mitochondrial effect Effects 0.000 abstract 1
- 238000003199 nucleic acid amplification method Methods 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 239000002777 nucleoside Substances 0.000 abstract 1
- 150000003833 nucleoside derivatives Chemical class 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 238000003753 real-time PCR Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Psychology (AREA)
- Virology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29352301P | 2001-05-29 | 2001-05-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE334232T1 true ATE334232T1 (de) | 2006-08-15 |
Family
ID=23129427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02729732T ATE334232T1 (de) | 2001-05-29 | 2002-05-29 | Pharmakologische anwendungen von mitochondriellen dna assays |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20030099933A1 (de) |
| EP (1) | EP1395681B1 (de) |
| JP (1) | JP4105626B2 (de) |
| AT (1) | ATE334232T1 (de) |
| AU (1) | AU2002302272B2 (de) |
| CA (1) | CA2416332C (de) |
| DE (1) | DE60213406T2 (de) |
| ES (1) | ES2269690T3 (de) |
| IL (1) | IL159047A0 (de) |
| WO (1) | WO2002097124A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004533805A (ja) | 2000-10-18 | 2004-11-11 | フアーマセツト・リミテツド | 疾患細胞中の核酸の多重定量 |
| KR20040034582A (ko) * | 2000-12-04 | 2004-04-28 | 프리마겐 홀딩 비.브이. | 내공생체 세포소기관의 시험 및 그것에 의해 동정할 수있는 화합물 |
| US20050153381A1 (en) * | 2002-02-14 | 2005-07-14 | Marusich Michael F. | Immunocapture of mitochondrial protein complexes |
| NL1021160C2 (nl) * | 2002-07-26 | 2004-01-27 | Multigen Internat B V | Werkwijze voor het bepalen van het kopieaantal van een nucleotidevolgorde. |
| EP1418241A1 (de) * | 2002-11-08 | 2004-05-12 | PrimaGen Holding B.V. | Methode zur Quantifizierung des Verhältnisses zweier Nukleinsäuresequenzen |
| GB0708507D0 (en) | 2007-05-02 | 2007-06-13 | Queen Mary & Westfield College | Substituted phosphonates and their use |
| US8346485B2 (en) | 2008-11-25 | 2013-01-01 | Quest Diagnostics Investments Incorporated | Methods and apparatuses for estimating initial target nucleic acid concentration in a sample by modeling background signal and cycle-dependent amplification efficiency of a polymerase chain reaction |
| JP5535571B2 (ja) * | 2009-10-14 | 2014-07-02 | 日本メナード化粧品株式会社 | 表皮ターンオーバーの評価方法及びその用途 |
| WO2012097849A2 (en) * | 2011-01-18 | 2012-07-26 | Merck Patent Gmbh | Mitochondrial genome-restricted dna sequences |
| US9080205B2 (en) | 2012-03-30 | 2015-07-14 | The United States of America as represented by the Federal Bureau of Investigation, Department of Justice | Quantification of human mitochondrial DNA using synthesized DNA standards |
| ES2482866B1 (es) * | 2012-11-22 | 2015-05-12 | Consejo Superior De Investigaciones Científicas (Csic) | Método de diagnóstico y/o pronóstico de enfermedades neurodegenerativas. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7638501B1 (en) * | 1999-02-23 | 2009-12-29 | The Regents Of The University Of California | Method of treatment of mitochondrial disorders |
| WO2001035096A2 (en) * | 1999-11-10 | 2001-05-17 | Mitokor | Diseases associated with altered mitochondrial function |
| JP2004533805A (ja) * | 2000-10-18 | 2004-11-11 | フアーマセツト・リミテツド | 疾患細胞中の核酸の多重定量 |
-
2002
- 2002-05-29 CA CA2416332A patent/CA2416332C/en not_active Expired - Lifetime
- 2002-05-29 DE DE60213406T patent/DE60213406T2/de not_active Expired - Lifetime
- 2002-05-29 EP EP02729732A patent/EP1395681B1/de not_active Expired - Lifetime
- 2002-05-29 ES ES02729732T patent/ES2269690T3/es not_active Expired - Lifetime
- 2002-05-29 JP JP2003500289A patent/JP4105626B2/ja not_active Expired - Lifetime
- 2002-05-29 IL IL15904702A patent/IL159047A0/xx unknown
- 2002-05-29 AU AU2002302272A patent/AU2002302272B2/en not_active Ceased
- 2002-05-29 US US10/158,543 patent/US20030099933A1/en not_active Abandoned
- 2002-05-29 AT AT02729732T patent/ATE334232T1/de not_active IP Right Cessation
- 2002-05-29 WO PCT/CA2002/000796 patent/WO2002097124A1/en not_active Ceased
-
2007
- 2007-07-11 US US11/776,481 patent/US20090053697A1/en not_active Abandoned
-
2010
- 2010-10-29 US US12/916,406 patent/US20110184051A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20090053697A1 (en) | 2009-02-26 |
| AU2002302272B2 (en) | 2008-05-22 |
| CA2416332A1 (en) | 2002-12-05 |
| JP4105626B2 (ja) | 2008-06-25 |
| IL159047A0 (en) | 2004-05-12 |
| US20110184051A1 (en) | 2011-07-28 |
| DE60213406T2 (de) | 2007-03-08 |
| JP2004532043A (ja) | 2004-10-21 |
| EP1395681A1 (de) | 2004-03-10 |
| WO2002097124A1 (en) | 2002-12-05 |
| DE60213406D1 (de) | 2006-09-07 |
| ES2269690T3 (es) | 2007-04-01 |
| CA2416332C (en) | 2012-11-13 |
| EP1395681B1 (de) | 2006-07-26 |
| US20030099933A1 (en) | 2003-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kutyavin et al. | Oligonucleotides containing 2-aminoadenine and 2-thiothymine act as selectively binding complementary agents | |
| Nolan et al. | PCR technology: current innovations | |
| Iwatani et al. | Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G | |
| Cameron et al. | Mutations in HIV reverse transcriptase which alter RNase H activity and decrease strand transfer efficiency are suppressed by HIV nucleocapsid protein | |
| ES2118593T3 (es) | Analogos de nucleotidos de pteridina como sondas fluorescentes de adn. | |
| ATE334232T1 (de) | Pharmakologische anwendungen von mitochondriellen dna assays | |
| DE69433626D1 (de) | N-2 substituierte purine | |
| ATE416183T1 (de) | Oligonukleotide mit alternierenden segmenten und deren verwendungen | |
| DK3222722T3 (da) | Antisense-design | |
| KR960701219A (ko) | 사람의 면역결핍 바이러스 타입1의 검출(Detection of Human Immunodeficiency Virus Type 1) | |
| ATE557100T1 (de) | Doppelsträngige lineare nukleinsäuresonde und deren verwendung | |
| DE69838449D1 (de) | Aminooxy-modifizierte oligonukleotide | |
| DK0970240T3 (da) | Kunstig fejlparringshydridisering | |
| BR0109062A (pt) | Inibidores de frutose-1,6-bisfosfatase de arila | |
| BRPI0507960A (pt) | métodos terapêuticos empregando precursores de óxido nìtrico | |
| DE69815370D1 (de) | Fluoreszend-konjugaten von nukleosiden und von nukleotiden, ihrer verfahren zur herstellung und ihrer verwendungen | |
| Singh et al. | The effect of hairpin structure on PCR amplification efficiency | |
| Militello et al. | A map of 5-methylcytosine residues in Trypanosoma brucei tRNA revealed by sodium bisulfite sequencing | |
| Zelin et al. | Adenosine is inherently favored as the branch-site RNA nucleotide in a structural context that resembles natural RNA splicing | |
| Yelagandula et al. | SARSeq, a robust and highly multiplexed NGS assay for parallel detection of SARS-CoV2 and other respiratory infections | |
| WO2001029262A3 (en) | Genotyping reagents, kits and methods of use thereof | |
| DE602005022714D1 (de) | Hybridisierung von pna-sonden in alkohollösungen | |
| ATE526418T1 (de) | Verbesserte zusammensetzungen zur in-vitro- amplifikation von nukleinsäuren | |
| AU2003234932A1 (en) | Nucleic acid amplification primers for detecting cytokeratins and examination method with the use of the primers | |
| Lee et al. | Differential distribution of human mitochondrial DNA in somatic tissues and hairs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |